Page last updated: 2024-10-22

amsacrine and Carcinoma, Bronchial

amsacrine has been researched along with Carcinoma, Bronchial in 2 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Creech, RH2
Tritchler, D1
Ettinger, DS2
Ferraro, JA2
Ruckdeschel, JC2
Vogl, SE2
Woll, J1
Day, R1
Woll, JE1

Trials

2 trials available for amsacrine and Carcinoma, Bronchial

ArticleYear
Phase II study of PALA, amsacrine, teniposide, and zinostatin in small cell lung carcinoma (EST 2579).
    Cancer treatment reports, 1984, Volume: 68, Issue:9

    Topics: Aminoacridines; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Aspartic Acid; Carcin

1984
A randomized phase II study of m-AMSA (NSC 249992) and neocarzinostatin (NSC 157365) in non-small cell bronchogenic carcinoma. An Eastern Cooperative Group Study.
    American journal of clinical oncology, 1983, Volume: 6, Issue:2

    Topics: Aged; Aminoacridines; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Bron

1983